Search Results - "SORICE, GIAN PIO"

Removal of Duodenum Elicits GLP-1 Secretion by MUSCOGIURI, Giovanna, MEZZA, Teresa, PRIOLETTA, Annamaria, PIO SORICE, Gian, CLEMENTE, Gennaro, SARNO, Gerardo, NUZZO, Gennaro, PONTECORVI, Alfredo, HOLST, Jens J, GIACCARI, Andrea

“…To evaluate the effect of removal of the duodenum on the complex interplay between incretins, insulin, and glucagon in nondiabetic subjects. For evaluation of…”
Get full text

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives by Cefalo, Chiara Maria Assunta, Cinti, Francesca, Moffa, Simona, Impronta, Flavia, Sorice, Gian Pio, Mezza, Teresa, Pontecorvi, Alfredo, Giaccari, Andrea

“…Sotagliflozin is a dual sodium-glucose co-transporter-2 and 1 (SGLT2/1) inhibitor for the treatment of both type 1 (T1D) and type 2 diabetes (T2D)…”
Get full text

Glucagon in type 2 diabetes: Friend or foe? by Caruso, Irene, Marrano, Nicola, Biondi, Giuseppina, Genchi, Valentina Annamaria, D'Oria, Rossella, Sorice, Gian Pio, Perrini, Sebastio, Cignarelli, Angelo, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco

“…Hyperglucagonemia is one of the ‘ominous’ eight factors underlying the pathogenesis of type 2 diabetes (T2D). Glucagon is a peptide hormone involved in…”
Get full text

981-P: Transition from Standard Time to Daylight Saving Time and Vice Versa—Effects on FGM Metrics in Patients with Autoimmune Diabetes by DI GIOIA, LUDOVICO, DI MOLFETTA, SERGIO, GIORDANO, FIORELLA, CAPORUSSO, MARIANGELA, PIO SORICE, GIAN, CIGNARELLI, ANGELO, NATALICCHIO, ANNALISA, LAVIOLA, LUIGI, GIORGINO, FRANCESCO

“…Circadian rhythm variations, including transition from standard time (ST) to daylight saving time (DST), are associated with measurable effects on health. It…”
Get full text

Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity by Palma, Giuseppe, Sorice, Gian Pio, Genchi, Valentina Annamaria, Giordano, Fiorella, Caccioppoli, Cristina, D’Oria, Rossella, Marrano, Nicola, Biondi, Giuseppina, Giorgino, Francesco, Perrini, Sebastio

“…Obesity is a chronic disease caused by an excess of adipose tissue that may impair health by altering the functionality of various organs, including the lungs…”
Get full text

Insulin Resistance Alters Islet Morphology in Nondiabetic Humans by MEZZA, Teresa, MUSCOGIURI, Giovanna, SORICE, Gian Pio, CLEMENTE, Gennaro, JIANG HU, PONTECORVI, Alfredo, HOLST, Jens J, GIACCARI, Andrea, KULKARNI, Rohit N

“…Type 2 diabetes is characterized by poor glucose uptake in metabolic tissues and manifests when insulin secretion fails to cope with worsening insulin…”
Get full text

Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies by Caruso, Irene, Cignarelli, Angelo, Sorice, Gian Pio, Natalicchio, Annalisa, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco

“…Cardiovascular outcome trials (CVOT) showed that treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) is associated with significant…”
Get full text

Diet and Proteinuria: State of Art by Ria, Paolo, De Pascalis, Antonio, Zito, Anna, Barbarini, Silvia, Napoli, Marcello, Gigante, Antonietta, Sorice, Gian Pio

“…Proteinuria is a broad term used to describe the pathological presence of proteins, including albumin, globulin, Bence-Jones protein, and mucoprotein in the…”
Get full text

Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report by Leccisotti, Lucia, Cinti, Francesca, Sorice, Gian Pio, D’Amario, Domenico, Lorusso, Margherita, Guzzardi, Maria Angela, Mezza, Teresa, Gugliandolo, Shawn, Cocchi, Camilla, Capece, Umberto, Indovina, Luca, Ferraro, Pietro Manuel, Iozzo, Patricia, Crea, Filippo, Giordano, Alessandro, Giaccari, Andrea

“…Abstract Objective Cardiovascular (CV) outcome trials have shown that in patients with type 2 diabetes (T2D), treatment with sodium-glucose cotransporter-2…”
Get full text

Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis by Di Molfetta, Sergio, Di Gioia, Ludovico, Caruso, Irene, Cignarelli, Angelo, Green, Suetonia C., Natale, Patrizia, Strippoli, Giovanni F. M., Sorice, Gian Pio, Perrini, Sebastio, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco

“…ABSTRACT Aims To compare the efficacy and safety of different hybrid closed loop (HCL) systems in people with diabetes through a network meta‐analysis. Methods…”
Get full text

HCC development is associated to peripheral insulin resistance in a mouse model of NASH by De Minicis, Samuele, Agostinelli, Laura, Rychlicki, Chiara, Sorice, Gian Pio, Saccomanno, Stefania, Candelaresi, Cinzia, Giaccari, Andrea, Trozzi, Luciano, Pierantonelli, Irene, Mingarelli, Eleonora, Marzioni, Marco, Muscogiuri, Giovanna, Gaggini, Melania, Benedetti, Antonio, Gastaldelli, Amalia, Guido, Maria, Svegliati-Baroni, Gianluca

“…NAFLD is the most common liver disease worldwide but it is the potential evolution to NASH and eventually to hepatocellular carcinoma (HCC), even in the…”
Get full text

Medical therapy of aortic aneurysms: a pathophysiology-based approach by Muscogiuri, Giovanna, Sorice, Gian Pio, Tripathy, Devjit, Chavez, Alberto O, Davalli, Alberto, Lange, Richard A, Folli, Franco

“…One of the critical points in the pathogenesis of aortic aneurysms (AAs) is the disruption of the balance between vascular extracellular matrix (ECM)…”
Get more information

Incretin-based therapies for the treatment of obesity-related diseases by Caruso, Irene, Cignarelli, Angelo, Sorice, Gian Pio, Perrini, Sebastio, Giorgino, Francesco

“…Obesity-related disability-adjusted life years (DALYs) are expected to increase by approximately 40% from 2020 to 2030. DALYs and mortality related to obesity…”
Get full text

The Interplay between Immune System and Microbiota in Diabetes by Giaccari, Andrea, Pontecorvi, Alfredo, Santoro, Antonio, Sorice, Gian Pio, Impronta, Flavia, Cinti, Francesca, Cefalo, Chiara M. A., Mezza, Teresa, Moffa, Simona, Di Giuseppe, Gianfranco

“…Diabetes is not a single and homogeneous disease, but a cluster of metabolic diseases characterized by the common feature of hyperglycemia. The pathogenesis of…”
Get full text

Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes by Cinti, Francesca, Leccisotti, Lucia, Sorice, Gian Pio, Capece, Umberto, D'Amario, Domenico, Lorusso, Margherita, Gugliandolo, Shawn, Morciano, Cassandra, Guarneri, Andrea, Guzzardi, Maria Angela, Mezza, Teresa, Capotosti, Amedeo, Indovina, Luca, Ferraro, Pietro Manuel, Iozzo, Patricia, Crea, Filippo, Giordano, Alessandro, Giaccari, Andrea

“…We recently demonstrated that treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) leads to an increase in myocardial flow reserve in patients…”
Get full text

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis by Cignarelli, Angelo, Genchi, Valentina Annamaria, Le Grazie, Giulia, Caruso, Irene, Marrano, Nicola, Biondi, Giuseppina, D'Oria, Rossella, Sorice, Gian Pio, Natalicchio, Annalisa, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco

“…Accumulating evidence supports the early use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose transporter-2 inhibitors (SGLT-2is) for…”
Get full text

Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date by Cinti, Francesca, Moffa, Simona, Impronta, Flavia, Cefalo, Chiara Ma, Sun, Vinsin A, Sorice, Gian Pio, Mezza, Teresa, Giaccari, Andrea

“…Sodium-glucose cotransporter 2 (SGLT2) inhibitors are the latest therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM). Using an…”
Get full text

Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis by Mezza, Teresa, Moffa, Simona, Ferraro, Pietro Manuel, Quero, Giuseppe, Capece, Umberto, Carfì, Andrea, Cefalo, Chiara M A, Cinti, Francesca, Sorice, Gian Pio, Impronta, Flavia, Mari, Andrea, Pontecorvi, Alfredo, Alfieri, Sergio, Holst, Jens J, Giaccari, Andrea

“…Abstract Objective Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission…”
Get full text

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? by Muscogiuri, Giovanna, Sorice, Gian Pio, Prioletta, Annamaria, Mezza, Teresa, Cipolla, Clelia, Salomone, Enrica, Giaccari, Andrea, Pontecorvi, Alfredo, Della Casa, Silvia

“…Summary Context  Adrenal incidentalomas (AI) have often been associated with a high prevalence of insulin resistance (IR) and cardiovascular risk factors,…”
Get full text

Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy by Mezza, Teresa, M.D, Clemente, Gennaro, M.D, Sorice, Gian Pio, M.D, Conte, Caterina, M.D, De Rose, Agostino Maria, M.D, Sun, Vincin Alice, M.D, Cefalo, Chiara Maria Assunta, M.D, Pontecorvi, Alfredo, M.D., Ph.D, Nuzzo, Gennaro, M.D, Giaccari, Andrea, M.D., Ph.D

“…Abstract Background Pancreaticoduodenectomy represents the major treatment for pancreatic and periampullary neoplasms. Complications related to…”
Get full text